-
A project that started out as a response to post-9/11 bioterrorism fears is turning out to have much more practical everyday applications, say two ED managers who have pioneered the use of a system that monitors for unusual patterns or patient surges. While still valuable for detecting terrorist attacks, the system can reveal more mundane but useful information in any ED, they say.
-
These were some other key findings from the diversion study released recently by the Center for Studying Health System Change (HSC) in Washington, DC.
-
Medicaid recipients with chronic diseases are a difficult population to reach. Often, they're transient and face economic, linguistic, and cultural barriers to health care. Thats why McKesson Corp., based in San Francisco, came up with a series of outside-the-box initiatives in its disease management programs for Medicaid patients whose care is not covered by a managed care contract.
-
Some people who are considering bariatric surgery as a weight-loss option may think they can have a minor operation and start losing weight automatically without having to think of dieting again. Thats where Michelle Coffman, RN, and Sue Lassetter, MA, come in.
-
-
The Today contraceptive sponge awaits the results of a Food and Drug Administration (FDA) review to return to the shelves in the United States. After being approved by the FDA in 1983, the sponge achieved considerable popularity before production was discontinued in 1995. Since then, Allendale (NJ) Pharmaceuticals has purchased rights to the Today sponge and has been working to bring the product back to the United States.
-
Current health care research and service development all too often misses the target, according to presenters during the Translating Research Into Practice: Advancing Excellence from Discovery to Delivery, conference held in Washington, DC, in July.
-
-
-
Crisis response mode and rapidly emerging infections are the new normal for a public health system that has to expect new threats as part of the daily job, warned Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention (CDC).
